Geode Capital Management’s Royalty Pharma RPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $299M | Buy |
8,176,504
+177,036
| +2% | +$6.48M | 0.02% | 539 |
|
|
2025
Q1 | $253M | Buy |
7,999,468
+686,917
| +9% | +$21.8M | 0.02% | 567 |
|
|
2024
Q4 | $187M | Buy |
7,312,551
+46,765
| +0.6% | +$1.19M | 0.01% | 658 |
|
|
2024
Q3 | $206M | Buy |
7,265,786
+417,490
| +6% | +$11.8M | 0.02% | 623 |
|
|
2024
Q2 | $180M | Buy |
6,848,296
+300,242
| +5% | +$7.9M | 0.02% | 633 |
|
|
2024
Q1 | $199M | Buy |
6,548,054
+180,443
| +3% | +$5.47M | 0.02% | 594 |
|
|
2023
Q4 | $179M | Buy |
6,367,611
+266,057
| +4% | +$7.49M | 0.02% | 586 |
|
|
2023
Q3 | $166M | Sell |
6,101,554
-44,310
| -0.7% | -$1.2M | 0.02% | 578 |
|
|
2023
Q2 | $189M | Buy |
6,145,864
+153,738
| +3% | +$4.72M | 0.02% | 549 |
|
|
2023
Q1 | $216M | Buy |
5,992,126
+165,332
| +3% | +$5.95M | 0.03% | 497 |
|
|
2022
Q4 | $230M | Buy |
5,826,794
+555,060
| +11% | +$21.9M | 0.03% | 470 |
|
|
2022
Q3 | $212M | Buy |
5,271,734
+220,646
| +4% | +$8.86M | 0.03% | 468 |
|
|
2022
Q2 | $212M | Buy |
5,051,088
+41,439
| +0.8% | +$1.74M | 0.03% | 481 |
|
|
2022
Q1 | $195M | Sell |
5,009,649
-294,473
| -6% | -$11.5M | 0.02% | 543 |
|
|
2021
Q4 | $211M | Buy |
5,304,122
+1,136,073
| +27% | +$45.2M | 0.03% | 536 |
|
|
2021
Q3 | $151M | Buy |
4,168,049
+2,183,363
| +110% | +$78.8M | 0.02% | 608 |
|
|
2021
Q2 | $81.2M | Buy |
1,984,686
+54,236
| +3% | +$2.22M | 0.01% | 932 |
|
|
2021
Q1 | $84.1M | Buy |
1,930,450
+677,943
| +54% | +$29.5M | 0.01% | 873 |
|
|
2020
Q4 | $62.6M | Buy |
1,252,507
+167,664
| +15% | +$8.38M | 0.01% | 957 |
|
|
2020
Q3 | $45.6M | Buy |
1,084,843
+254,569
| +31% | +$10.7M | 0.01% | 969 |
|
|
2020
Q2 | $40.3M | Buy |
+830,274
| New | +$40.3M | 0.01% | 1010 |
|